公开(公告)号：US20170368043A1

公开(公告)日：2017-12-28

申请号：US15694363

申请日：2017-09-01

Applicant: ChemoCentryx, Inc.

Inventor： Petrus Bekker ,  Shichang Miao ,  Israel Charo ,  Tom Schall

IPC: A61K31/444 ,  A61K31/519 ,  A61K31/506 ,  A61K31/282 ,  A61K31/4745 ,  A61K31/337 ,  A61K31/7068 ,  A61K31/513

CPC classification number: A61K31/444 ,  A61K31/282 ,  A61K31/337 ,  A61K31/4745 ,  A61K31/506 ,  A61K31/513 ,  A61K31/519 ,  A61K31/555 ,  A61K31/7068 ,  A61K45/06 ,  A61K2300/00

Abstract: The present disclosure describes methods of treating pancreatic cancer and limiting over-expression of oncogenes, activating tumor suppressor genes or regulating signaling proteins in patients comprising administering compounds and pharmaceutical combinations as described herein.

公开(公告)号：US10583131B2

公开(公告)日：2020-03-10

申请号：US16527933

申请日：2019-07-31

Applicant: ChemoCentryx, Inc.

Inventor： Petrus Bekker ,  Shichang Miao ,  Israel Charo ,  Tom Schall

IPC: A61K31/444 ,  A61K31/506 ,  A61K31/37 ,  A61K31/7068 ,  A61K31/4745 ,  A61K31/555 ,  A61K31/513 ,  A61K31/519 ,  A61K45/06 ,  A61K31/282 ,  A61K31/53 ,  A61K38/19 ,  A61K31/337

Abstract: The present disclosure describes methods of treating pancreatic cancer and limiting over-expression of oncogenes, activating tumor suppressor genes or regulating signaling proteins in patients comprising administering compounds and pharmaceutical combinations as described herein.

公开(公告)号：US10251888B2

公开(公告)日：2019-04-09

申请号：US15621749

申请日：2017-06-13

Applicant: ChemoCentryx, Inc.

Inventor： Petrus Bekker ,  Shichang Miao ,  Israel Charo ,  Tom Schall

IPC: A61K31/444 ,  A61K31/519 ,  A61K45/06

Abstract: The present disclosure describes methods of treating pancreatic cancer and limiting over-expression of oncogenes, activating tumor suppressor genes or regulating signaling proteins in patients comprising administering compounds and pharmaceutical combinations as described herein.

公开(公告)号：US20170354657A1

公开(公告)日：2017-12-14

申请号：US15621749

申请日：2017-06-13

Applicant: ChemoCentryx, Inc.

Inventor： Petrus Bekker ,  Shichang Miao ,  Israel Charo ,  Tom Schall

IPC: A61K31/519 ,  A61K31/444

CPC classification number: A61K31/519 ,  A61K31/444 ,  A61K45/06

Abstract: The present disclosure describes methods of treating pancreatic cancer and limiting over-expression of oncogenes, activating tumor suppressor genes or regulating signaling proteins in patients comprising administering compounds and pharmaceutical combinations as described herein.